The Global Respiratory Inhalers Market 2017-2027

Thursday, March 30, 2017 Respiratory Disease News
Email Print This Page Comment
Font : A-A+

LONDON, March 30, 2017 /PRNewswire/ --

Revenue Prospects by Product Type (Metered Dose

Inhalers, Dry Powder Inhalers, Nebulizers), by Indication (Asthma and COPD) and Geography

Respiratory Inhalers - our new study reveals trends, R&D progress, and predicted revenues Where is the Respiratory Inhalers market

heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead Our 181-page report provides 118 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Respiratory Inhalers market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, 8 Products and 3 indications are also forecasted.

Respiratory Inhalers Market Forecasts to 2027, by Product: • Metered Dose Inhalers • Dry Powder Inhalers - Single-Dose DPIs - Multi-Dose DPIs • Nebulizers - Jet / Compressor Nebulizers - Ultrasonic Nebulizers - Vibrating-Mesh Nebulizers

Respiratory Inhalers Market Forecasts to 2027, by Application: • Asthma • COPD • Other Respiratory Diseases

To see a report overview, please email Sara Peerun on sara.peerun@visiongainglobal.com

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 12 leading national markets: • The US • The EU5 markets - Germany - France - UK - Italy - Spain • Japan • China • India • Russia • Brazil • Mexico

The report also includes profiles and forecasts for some of the leading companies in the Respiratory Inhalers device market, with a focus on the Respiratory Inhalers device segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth Overall world revenue for Respiratory Inhalers will surpass $33.2bn in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing use of Respiratory Inhalers across many types of surgery and increasing ageing population will increase sales to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Respiratory Inhalers Market report helps you In summary, our 181-page report provides you with the following knowledge: • Revenue forecasts to 2027 for the world Respiratory Inhalers market and 2 different segmentations, with 8 product types and 3 applications - discover the industry's prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for 12 of the leading national markets - US, Mexico, Brazil, Germany, UK, France, Italy, Spain, Japan, China, India, the Rest of World markets. • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Respiratory Inhalers device market and leading companies. You find data, trends and predictions.

Get our report today The Global Respiratory Inhalers Market 2017-2027: Revenue Prospects by Product Type (Metered Dose Inhalers, Dry Powder Inhalers, Nebulizers), by Indication (Asthma and COPD) and Geography. Avoid missing out - get our report now.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44-(0)-20-7336-6100

Or click on: https://www.visiongain.com/Report/1828/The-Global-Respiratory-Inhalers-Market-2017-2027

List of Companies  

3M Drug Delivery Systems

Actavis

Adherium Limited

Aerogen

Agilent Technology

Airssential

Allied Healthcare

Almirall

Astrazeneca

Boehringer Ingelheim

Briggs Healthcare

CareFusion

Chiesi

Cipla

Clement Clarke International

Cohero Health

DeVilbiss Healthcare

Fexicare

Gecko Health Innovations

GF Health Products

GlaxoSmithKline

Heyer Medical

Hikma

Innovate Biomed

Inspiro Medical

Medline Surgical

Merck

MRK Healthcare

Mylan

Nexus 6

Nouvag AG

Novartis

Omron Healthcare

Opko Health

Orion Pharma

PARI Medical

Pfizer

Philips Respironics

Propeller Health

Qualcomm Incorporated

Roche

Schering-Plough

Sunovion Pharma

Takeda Pharmaceutical Company Limited

Teva Pharmaceuticals

Vectura

Viatris

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

SOURCE Visiongain Ltd



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook